Open AccessNew‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
Author(s) -
Kaminetsky Joshua,
Rudikoff Donald
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4865
Subject(s) - medicine , vaccination , covid-19 , vitiligo , dermatology , messenger rna , virology , immunology , outbreak , disease , gene , infectious disease (medical specialty) , biochemistry , chemistry
The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom